Close

Feltl & Co Upgrades Cardiovascular Systems (CSII) to Strong Buy

Go back to Feltl & Co Upgrades Cardiovascular Systems (CSII) to Strong Buy

Cardiovascular Systems (CSII) Tops Q1 EPS by 13c

October 26, 2016 4:43 PM EDT

Cardiovascular Systems (NASDAQ: CSII) reported Q1 EPS of ($0.06), $0.13 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $49.8 million versus the consensus estimate of $49.01 million.

GUIDANCE:

Cardiovascular Systems sees Q2 2017 revenue of $49-50 million, versus the consensus of $49.55... More